全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 1496552-16-9 | Sofosbuvir Impurity 50;Sofosbuvir impurity A;propan-2-yl (2R)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate | C22H29FN3O9P |
| 1496552-28-3 | N-[[P(S),2'R]-2'-Deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-D-alanine 1-methylethyl ester | C22H29FN3O9P |
| 1496581-76-0 | 2-[[6-(3,3-Difluoro-1-pyrrolidinyl)-4-[1-(3-oxetanyl)-4-piperidinyl]-2-pyridinyl]amino]-4-pyridinecarbonitrile | C23H26F2N6O |
| 1496637-05-8 | (11bS)-4-Hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin 4-oxide | C56H37O4P |
| 1496997-41-1 | 2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione | C13H8F2N2O4 |
| 1499167-72-4 | Azilsartan Impurity 8;methyl 3-[[4-[2-[(E)-(hydroxyhydrazinylidene)methyl]phenyl]phenyl]methyl]-2-oxo-1H-benzimidazole-4-carboxylate | C23H20N4O4 |
| 1499193-60-0 | 2-Bromo-9,9-difluoro-7-iodo-9H-fluorene | C13H6BrF2I |
| 1499193-67-7 | (6S)-6-[5-[7-[2-(1R,3S,4S)-2-Azabicyclo[2.2.1]hept-3-yl-1H-benzimidazol-6-yl]-9,9-difluoro-9H-fluoren-2-yl]-1H-imidazol-2-yl]-5-azaspiro[2.4]heptane hydrochloride (1:4) | C35H32F2N6.4(HCl) |
| 1500106-31-9 | potassium (T-4)-trifluoro-1-propyn-1-yl-Borate | C3H3BF3.K |
| 1502816-23-0 | N-Methyl-4-(phenylmethoxy)-1-piperidineethanamine | C15H24N2O |
| 1503408-77-2 | 6-Chloro-3,4-dimethylpyridin-2-amine | C7H9ClN2 |
| 1504965-88-1 | 5-Amino-2-fluoro-4-methylbenzoic acid methyl ester;Methyl 5-amino-2-fluoro-4-methylbenzoate | C9H10FNO2 |
| 1505453-59-7 | (4S)-6-(4-Chlorophenyl)-1-methyl-8-(1-methyl-1H-pyrazol-4-yl)-4H-isoxazolo[5,4-d][2]benzazepine-4-acetamide | C24H20ClN5O2 |
| 1505641-47-3 | 3-Bromo-5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazine¡ãC | C6H7BrN2O |
| 1505662-44-1 | 3-Acetyl-4-fluorobenzoic acid | C9H7FO3 |
| 1506066-94-9 | Octahydro-5-(phenylmethyl)-1H-pyrrolo[3,2-c]pyridine | C14H20N2 |
| 1507370-20-8 | N1,N2-Bis[[4-(2-pyridinyl)phenyl]methyl]-1,2-ethanediamine | C26H26N4 |
| 1507370-40-2 | N1,N2-Bis[[4-(2-thiazolyl)phenyl]methyl]-1,2-ethanediamine | C22H22N4S2 |
| 1507403-85-1 | 4MetBuXPhos Pd G3;Methanesulfonato(2-di-t-butylphosphino-3,4,5,6-tetramethyl-2',4',6'-tri-i-propylbiphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C46H66NO3PPdS |
| 1507404-60-5 | Methanesulfonato[2-(Di-1-adamantylphosphino)-2',4',6'-triisopropyl-3,6-dimethoxybiphenyl][2-(2'-amino-1,1'-biphenyl)]palladium(II);1-adamantyl-(2-adamantyl)-[3,6-dimethoxy-2-[2,4,6-tri(propan-2-yl)phenyl]phenyl]phosphanium palladium(2+) (2-phenylphenyl)azanide;trifluoromethanesulfonic acid | C56H71F3NO5PPdS |
| 1508250-71-2 | Nazartinib;N-[7-Chloro-1-[(3R)-1-[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]hexahydro-1H-azepin-3-yl]-1H-benzimidazol-2-yl]-2-methyl-4-pyridinecarboxamide; EGF 816 | C26H31ClN6O2 |
| 1508261-86-6 | 2-Methyl-L-proline hydrochloride;(2S)-2-methylpyrrolidine-2-carboxylic acid;hydrochloride | C6H11NO2.HCl |
| 1508892-33-8 | alpha,3-Dihydroxybenzenepropanoic acid methyl ester | C10H12O4 |
| 1510820-22-0 | Ezetimibe Dehydroxy Impurity;(3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)propyl]-4-(4-hydroxyphenyl)azetidin-2-one | C24H21F2NO2 |
| 1510821-28-9 | N-[2-(2-Ethoxyphenoxy)ethyl]-4-methoxy-alpha-methylbenzeneethanamine | C20H27NO3 |
| 1513253-45-6 | N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1H-imidazol-2-amine | C11H11N3O2 |
| 1515856-92-4 | 2-[(3S)-3-(2-Pyridinylmethoxy)-1-pyrrolidinyl]-5-(trifluoromethyl)benzoic acid | C18H17F3N2O3 |
| 1516140-99-0 | Tetrahydro-2H-pyran-4-sulfinic acid sodium salt (1:1) | C5H9O3S.Na |
| 1516895-53-6 | rel-2-[(1R,2R)-2-(5,8-Dimethyl[1,2,4]triazolo[1,5-a]pyrazin-2-yl)cyclopropyl]-3-methylimidazo[2,1-f][1,6]naphthyridine | C21H19N7 |
| 1517576-71-4 | 6-Bromo-2,3-difluorophenylacetonitrile | C8H4BrF2N |
| 1517611-20-9 | 2-Bromo-3,4-difluorobenzonitrile | C7H2BrF2N |
| 1522098-73-2 | 4-(Hydroxymethyl)-2-azabicyclo[2.1.1]hexane-1-carboxylic acid | C7H11NO3 |
| 1522718-34-8 | 1-Methyl-3-(3-nitrophenyl)imidazolidin-2-one | C10H11N3O3 |
| 1523406-39-4 | (8S)-9-[(5-Chloro-3-pyridinyl)methyl]-6,7,8,9-tetrahydro-2-[(3R)-3-methyl-4-morpholinyl]-8-(trifluoromethyl)-4H-pyrimido[1,2-a]pyrimidin-4-one;SAR 405 | C19H21ClF3N5O2 |
| 1523530-25-7 | (3R,4R)-4-Fluoro-3-pyrrolidinol hydrochloride (1:1) | C4H8FNO.HCl |
| 1523530-29-1 | N-[(3R,4R)-3-Fluoro-4-piperidinyl]carbamic acid 1,1-dimethylethyl ester | C10H19FN2O2 |
| 1523530-36-0 | cis-4-Amino-1-boc-3-hydroxypiperidine | C10H20N2O3 |
| 1523530-42-8 | (1R,3R)-3-Aminocyclopentanol hydrochloride (1:1) | C5H11NO.HCl |
| 1523541-74-3 | (1R,3R)-3-Aminocyclopentanol hydrochloride (1:1) | C5H11NO.HCl |
| 1523541-82-3 | (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid hydrochloride | C5H9ClFNO2 |
| 1523571-08-5 | tert-Butyl 2,6-diazaspiro[3.5]nonane-2-carboxylate hemioxalate | 2(C12H22N2O2).C2H2O4 |
| 1523571-10-9 | 1,6-Diazaspiro[3.3]heptane-1-carboxylic acid 1,1-dimethylethyl ester ethanedioate (2:1) | 2(C10H18N2O2).C2H2O4 |
| 1523571-19-8 | 1-(3-Oxetanyl)piperazine ethanedioate (2:1) | 2(C7H14N2O).C2H2O4 |
| 1523572-06-6 | N1,N3-Dimethylbicyclo[1.1.1]pentane-1,3-diamine hydrochloride (1:2) | C7H14N2.2(HCl) |
| 1523618-12-3 | 3,3-Difluoropiperidin-4-one hydrochloride | C5H8ClF2NO |
| 1527473-33-1 | 3-[4-(4-Morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile;PF 06447475 | C17H15N5O |
| 1527475-61-1 | 1-methyl-4-(4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)pyrrole-2-carbonitrile;PFE-360 | C16H16N6O |
| 1527479-23-7 | [4-(Adamantan-1-yl)phenyl]boronic acid | C16H21BO2 |
| 1528636-39-6 | Methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-alpha-D-xylo-hexopyranoside | C23H29ClO8 |
| 1529613-64-6 | 3-Amino-4-bromo-2,6-difluorobenzoic acid methyl ester | C8H6BrF2NO2 |